KDR and malignant glioma: As previously explained, malignant gliomas need extensive vascularity, so they commonly feature high expression of VEGF to allow new blood vessel formation, whereas tumor-associated endothelial cells express the corresponding receptor, vascular endothelial growth factor receptor 2 (VEGFR-2) [25].